Nav: Home

Study: Self-management program for patients with COPD boosts quality of life, cuts rehospitalization

November 20, 2018

Johns Hopkins Medicine researchers report that a program designed to enhance self-care and lead to more seamless management of chronic obstructive pulmonary disease (COPD) in adults successfully reduced rates of emergency room visits and hospitalization, and the burdensome symptoms and limitations caused by the condition.

Describing results of the six-month trial of the program in the Nov. 12 issue of The Journal of the American Medical Association, the investigators said patients in the new program (called BREATHE) were re-hospitalized at half the rate of a similar group of patients who received standard care without the program. BREATHE patients also reported improved quality of life, the research team said--a boon to high value health care efforts being made in the field of medicine.

"When a person with COPD gets admitted to the hospital with difficulty breathing, the doctors and nurses focus on their immediate problem and not their chronic disease and overall health, and so the chance that the person will have another flare-up and end up in the hospital again remains high," says lead author Hanan Aboumatar, M.D., M.P.H., associate professor of medicine at the Johns Hopkins University School of Medicine. "About half of patients will end up back in the hospital within six months."

"COPD is incurable and chronic, and our new program--which combines hospital to home transition support with chronic disease management support--is one way of reorganizing care in a way that reduces future hospitalization risk and expenses, while preserving patients' quality of life," she adds.

COPD is a label applied to a group of chronic conditions --including emphysema and chronic bronchitis-- that damage the lungs and cause breathing problems. An estimated 16 million Americans are living with COPD, generating costs to the health care system of more than $30 billion annually, according to the Centers for Disease Control and Prevention.

Smoking, air pollution, lung injury and genetics can all play a role in the development of COPD. Coughing, shortness of breath and wheezing symptoms range in severity, and people with COPD often experience worsening flare-ups over time.

Because the damage is irreversible and progressive, treatment focus is on symptom management with drugs, oxygen, and lifestyle changes. Previous studies have shown that patients who follow a set of strategies to manage their COPD do much better and have a greater quality of life, says Aboumatar, but "getting these strategies to patients and ensuring their successful use has been a challenge."

To address that challenge, Aboumatar and her colleagues teamed up with COPD patients and caregivers to design a program that would give patients better support immediately after being hospitalized with a COPD flare-up.

Specifically, the program--delivered to COPD patients admitted to medical units at the Johns Hopkins Bayview Medical Center between March 2015 and May 2016--paired patients and their family caregivers with a COPD nurse who met with them during hospitalization. The nurse continued consultation with the patient and caregiver, on average, 6.1 times over the three months after hospitalization through phone calls and/or home visits depending on patients' preference.

The nurse offered tailored support on how to take medications, use inhalers and breathing techniques, and manage COPD symptoms. In addition, the nurse worked through issues patients may face when living with COPD, including access to care, mobility services and other community resources.

Overall, 240 patients hospitalized for COPD were randomized to receive either the standard of care or the new three-month program. The control and intervention groups had average patient ages of 63.9 and 66, respectively, were 36.7 and 40 percent men, and 83.3 and 81.6 percent white. Participants in both groups had been diagnosed with COPD for an average of three years. The patients' hospitalizations and emergency department visits, as well as quality of life scores, were tracked for six months from the time of initial hospitalization.

Some 203 patients completed the six months of follow-up. During that time, there were 15 deaths and 337 subsequent hospitalizations. The number of COPD-related acute care events--either hospitalization or emergency department visits--per participant was 1.4 in the control group and 0.72 among those enrolled in the new program.

In addition, the quality of life-- as measured by a standard questionnaire known as the St. George's Respiratory Questionnaire--showed better scores in the intervention compared to the control group. While the score declined by 1.53 points on average over the six months of study for those in the intervention group, it increased by 5.44 points for those in the control group. The St. George's Respiratory Questionnaire scores range from 0-100 (lower scores indicate better quality of life), and a four-point difference on the 100 point scale is considered clinically meaningful.

"Our findings support the idea that a comprehensive program that reorganizes care for patients to help address long-term COPD self-management at a time when they're already struggling with a hospitalization due to a COPD flare-up is more effective than limited support that is focused on recovery from the current hospitalization," says Aboumatar. "When hospitalized due to a COPD flare-up, this condition becomes more of a priority, so it's a good moment to start a conversation with a patient about what they can do to successfully manage it." Aboumatar adds that having the same nurse interact with patients both in the hospital setting and after discharge helped build a relationship that allowed the patients to communicate effectively with and trust their nurse.

Aboumatar and her colleagues plan to test the program in other settings. She acknowledges that the program may be less feasible in rural areas, where patients and resources are more geographically spread out. The program is also being adapted for potential use with other chronic diseases marked by acute flare-ups, such as congestive heart failure.
-end-
The BREATHE program was developed in partnership with COPD patients, their family caregivers and clinicians of various disciplines.

Other authors on the paper include Mohammad Naqibuddin, Suna Chung, Hina Chaudhry, Samuel Kim, Jamia Saunders, Lee Bone, Ayse Gurses, Amy Knowlton, Peter Provonost, Nirupama Putcha, Cynthia Rand, Debra Roter, Carol Sylvester, Carol Thompson, Jennifer Wolff and Robert Wise of Johns Hopkins, and Judith Hibbard of the University of Oregon.

This work was supported by the Patient-Centered Outcomes Research Institute (Award HIS 1304-7118

Johns Hopkins Medicine

Related Copd Articles:

Treatment seeks to address exacerbations of COPD
A new study finds that delivery of oxygen via high-flow nasal tubes may help patients who experience exacerbations of chronic obstructive pulmonary disease (COPD).
Study reveals surprises concerning COPD and smoking
A new study challenges the widely accepted but oversimplified description of airway inflammation in smokers and patients with chronic obstructive pulmonary disease (COPD).
New guidelines for treatment and management of COPD exacerbations
A multi-disciplinary ERS/ATS task force of chronic obstructive pulmonary disease (COPD) experts has published comprehensive new guidelines on the treatment of COPD exacerbations.
New genetic markers for COPD discovered
In a new Research Letter published in Nature Genetics on Feb.
COPD -- what causes the lungs to lose their ability to heal?
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
New technology detects COPD in minutes
Pioneering research by Professor Paul Lewis of Swansea University's Medical School into one of the most common lung diseases in the UK, Chronic Obstructive Pulmonary Disease, has led to the development of a new technology that can quickly and easily diagnose and monitor the condition.
COPD exacerbations lead to lung function decline, particularly among those with mild COPD
Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Depression decreases adherence to COPD maintenance medications
A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression.
Care for COPD: Could more be done?
Meilan Han, M.D., an associate professor of internal medicine at the University of Michigan and the medical director of the U-M Women's Respiratory Health Program, is the lead author on a new report that set out to provide a comprehensive view of COPD care in the US.
COPD symptoms common among smokers, even when undiagnosed
A new study in the New England Journal of Medicine finds that smokers, who wouldn't typically be diagnosed with chronic obstructive pulmonary disease, or COPD, are still showing symptoms consistent with the diagnosis.

Related Copd Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".